Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Atreca Inc. (BCEL)

22.07   1.33 (6.41%) 02-26 16:00
Open: 20.7 Pre. Close: 20.74
High: 22.35 Low: 20.21
Volume: 105,274 Market Cap: 617M
Atreca, Inc., a biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients. Atreca, Inc. was founded in 2010 and is headquartered in Redwood City, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 22.361 - 22.496 22.496 - 22.625
Low: 19.916 - 20.062 20.062 - 20.203
Close: 21.827 - 22.061 22.061 - 22.284

Technical analysis

as of: 2020-02-26 4:26:00 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 29.20     One year: 34.11
Support: Support1: 18.74    Support2: 14.87
Resistance: Resistance1: 25.00    Resistance2: 29.20
Pivot: 21.45
Moving Average: MA(5): 22.01     MA(20): 20.77
MA(100): 14.43     MA(250):
MACD: MACD(12,26): 1.34     Signal(9): 1.49
Stochastic oscillator: %K(14,3): 40.91     %D(3): 49.70
RSI: RSI(14): 59.18
52-week: High: 25.00  Low: 9.51  Change(%): 22.3
Average Vol(K): 3-Month: 18866  10-Days: 13705

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
BCEL has closed below upper band by 34.5%. Bollinger Bands are 16.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2019-12-08
5 Top NASDAQ Biotech and Pharma Stocks: Atreca Climbs 45 Percent
Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have moved their share prices. The post 5 Top NASDAQ Biotech and Pharma Stocks: Atreca Climbs 45 Percent appeared first on Investing News Network .

2019-12-03
Atreca Receives FDA Clearance of IND Application for ATRC-101
The company announced that the FDA has cleared its IND application for ATRC-101 and that it can begin its Phase 1b clinical trial. The post Atreca Receives FDA Clearance of IND Application for ATRC-101 appeared first on Investing News Network .

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 22.03
Shares Float (M) 14.23
% Held by Insiders 6.81
% Held by Institutions 89.37
Shares Short (K) 1050
Shares Short P. Month (K)

Stock Financials

EPS -6.360
Book Value (p.s.) 7.330
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.844
Qtrly Earnings Growth
Operating Cash Flow (M) -53.29
Levered Free Cash Flow (M)

Stock Valuations

P/E -3.47
P/E Growth Ratio 0.06
P/BV 3.01
P/S
P/CF -9.12

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.